The board shall place a substance in schedule III if it finds that:
1. The substance has a potential for abuse less than the substances listed in schedules I and II;
2. The substance has currently accepted medical use in treatment in the United States; and 3. Abuse of the substance may lead to moderate or low physical dependence or high psychological dependence.